<DOC>
	<DOCNO>NCT01350219</DOCNO>
	<brief_summary>The translational potential clinical application cord blood stem cell increase enormously recent year , mainly unique advantage include risk donor , ethical issue , low risk graft-versus-host disease ( GVHD ) , rapid availability , large resource worldwide . Human cord blood contain several type stem cell umbilical cord blood-derived multipotent stem cell ( CB-SC ) . CB-SC posse multiple biological property include expression embryonic stem ( ES ) cell characteristic , give rise different type cell immune modulation . Specifically , CB-SC function immune modulator lead control immune response , could turn use new approach overcome autoimmunity Type 1 diabetes ( T1D ) patients1 nonobese diabetic ( NOD ) mouse . Here , investigator develop novel Stem Cell Educator therapy use CB-SC explore therapeutic effectiveness Educator therapy T1D patient .</brief_summary>
	<brief_title>Stem Cell Educator Therapy Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Patients screen enrollment study clinical sign laboratory test meet diagnosis standard American Diabetes Association 2010 . Other key inclusion criterion presence least one autoantibody pancreatic islet Î² cell . Exclusion criterion clinically significant disease liver , kidney , heart . Additional exclusion criterion pregnancy , immunosuppressive medication , viral disease disease associated immunodeficiency .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Cord blood stem cell</keyword>
	<keyword>Immune modulation</keyword>
	<keyword>Stem cell educator</keyword>
	<keyword>Autoimmunity</keyword>
	<keyword>Islet beta cell regeneration</keyword>
	<keyword>Type 1 diabetes</keyword>
</DOC>